Minnesota FOIA #N008959702

A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of...

This purchase order, issued by the Twin Cities government agency, awards a contract to Battelle for a research project focused on developing proteomic assays for early ovarian cancer detection using routine Pap tests. The contract involves a single purchase of services valued at $155,781. The vendor, Battelle, is located in Richland, Washington, USA, and the award is classified under the NAICS code 541712 (Research and Development in the Physical, Engineering, and Life Sciences). The procurement was made on October 14, 2024, and the project emphasizes innovative liquid biopsy techniques. No specific contract period is indicated, suggesting a single-transaction award.

Description

A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection